Contemporary Management of HIV 2020

Gain expert insights on the latest data supporting contemporary HIV treatment across settings, including patients who are newly diagnosed, virologically suppressed, or experiencing virologic failure with resistance and/or challenging comorbidities, along with new and emerging ART strategies.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Roger Bedimo, MD, MS, FACP
Eric S. Daar, MD
Joseph J. Eron, Jr., MD
W. David Hardy, MD
Lisa Hightow-Weidman, MD, MPH
Princy N. Kumar, MD, FIDSA, MACP
Daniel R. Kuritzkes, MD
Paul E. Sax, MD
Babafemi Taiwo, MBBS
David A. Wohl, MD

First-line and Switch Strategies

Gain expert insights on the latest data on the use of contemporary HIV regimens across settings, including for patients who are newly diagnosed and as switch strategies for patients with viral suppression on their current regimen.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD W. David Hardy, MD Babafemi Taiwo, MBBS
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 18, 2020 Expired: September 17, 2021

Download this expert-authored slideset to review national guidelines, key study data, and individual considerations for optimizing the use of current ART regimens as initial HIV treatment and in switch strategies for patients with viral suppression who require a change in therapy.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Babafemi Taiwo, MBBS
Released: July 6, 2020

Listen to expert insights from W. David Hardy, MD, on optimizing initial antiretroviral therapy for treatment-naive patients with HIV.

W. David Hardy, MD Released: October 2, 2020

ART Strategies for Complex HIV Cases

Download this expert-authored slideset to review treatment strategies for complex HIV cases; topics include managing heavily treatment-experienced patients, modifying ART in patients with underlying ARV resistance, and considerations for first-line ART selection in patients with obesity.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
Released: September 1, 2020

Listen to expert insights from Joseph J. Eron, Jr., MD, and Jason Halperin, MD, MPH, on optimal management of complex HIV cases, including switching ART in a patient with potential underlying resistance and initiating ART in a patient with obesity.

Released: November 17, 2020

Emerging Approaches to Optimize ART

Download this expert-authored slideset to consider important clinical questions related to first-line ART, switch strategies for patients with virologic suppression, and use of antiretroviral drugs to prevent HIV infection, with an emphasis on the role of new and emerging strategies.

Joseph J. Eron, Jr., MD Princy N. Kumar, MD, FIDSA, MACP Paul E. Sax, MD Released: August 28, 2020

Heavily Treatment-Experienced Patients

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure and current management options for patients with multiclass drug resistance experiencing treatment failure.

Joseph J. Eron, Jr., MD Princy N. Kumar, MD, FIDSA, MACP Released: October 20, 2020

New Data From AIDS 2020

Download this expert-authored slideset to review new HIV study data on current ART regimens, investigational long-acting treatment, metabolic effects of ART, COVID-19 and HIV, and HIV prevention, presented at AIDS 2020: Virtual.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP David A. Wohl, MD
Released: September 8, 2020

Experts review and discuss the clinical implications of new HIV study data on current ART regimens, investigational long-acting treatment, metabolic effects of ART, COVID-19 and HIV, and HIV prevention, presented at AIDS 2020: Virtual.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Lisa Hightow-Weidman, MD, MPH David A. Wohl, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 11, 2020 Expired: September 10, 2021

New Data From CROI 2020

Download this expert-authored slideset to review the most clinically relevant new data presented at CROI 2020 covering a wide range of HIV management topics, including late-phase investigational ART strategies, weight gain and metabolic outcomes during ART, outcomes with ART during pregnancy, and rapid ART initiation.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Daniel R. Kuritzkes, MD
Released: April 14, 2020

Experts review and discuss the clinical implications of new HIV study data on current ART regimens, investigational long-acting treatment, weight gain and metabolic outcomes with ART, HIV prevention, and more, presented at CROI 2020.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Roger Bedimo, MD, MS, FACP Daniel R. Kuritzkes, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: May 12, 2020 Expired: May 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue